Anticipated Shortage

MILRINONE LACTATE INJECTION, USP

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MILRINONE LACTATE INJECTION, USP in Canada?

A shortage of MILRINONE LACTATE INJECTION, USP 1MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 16, 2026), but it has not started yet.

When will MILRINONE LACTATE INJECTION, USP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusAnticipated Shortage

Same-ingredient products on fileNone found

Affected strength1MG

Report last updated2026-10-16

Checked by MedShort2026-10-17

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

DIN

02244622

Strength

1MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

MILRINONE

Tier

Unrated

Last Updated

2026-10-16

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02267659